Table 4.
Patient characteristics and hospital outcomes by substance and helmet use.
Substance and no helmet use (N = 727) | No substance and helmet use (N = 95) | P value | Odds ratioa | 95% CI | |
---|---|---|---|---|---|
Patient characteristics | |||||
Agec | 37 (26–48) | 20 (15–40) | 0.000 | ||
Gender (male)b | 608 (83.6%) | 77 (81.1%) | 0.526 | ||
Injury severity scorec | 12 (6–19) | 10 (5–17) | 0.015 | ||
Admission injuries | |||||
Skinb | 624 (86.1%) | 73 (76.8%) | 0.018 | 1.86 | 1.10–3.13 |
Musculoskeletalb | 500 (69.0%) | 56 (58.6%) | 0.049 | 1.54 | 0.99–2.39 |
Traumatic brain injuryb | 508 (70.1%) | 52 (54.7%) | 0.003 | 1.93 | 1.25–2.98 |
Spinal injuryb | 9 (1.2%) | 1 (1.1%) | 0.877 | ||
Peripheral Nervous systemb | 25 (3.4%) | 1 (1.1%) | 0.210 | ||
Genitourinaryb | 38 (5.2%) | 5 (5.3%) | 0.993 | ||
Gastro intestinalb | 86 (11.9%) | 12 (12.6%) | 0.828 | ||
Cardiovascularb | 15 (2.1%) | 2 (2.1%) | 0.981 | ||
Eye-ocular adnexab | 21 (2.9%) | 2 (2.1%) | 0.661 | ||
Thoracic-lungb | 306 (42.2%) | 42 (44.2%) | 0.710 | ||
Outcomes | |||||
Hospital length of stay >3(d)b | 313 (53.3%) | 23 (34.8%) | 0.004 | 2.13 | 1.25–3.63 |
ICU length of stay >2(d)b | 165 (52.4%) | 9 (39.1%) | 0.220 | ||
Incidence of ICU admissionb | 397 (54.6%) | 27 (28.4%) | 0.000 | 3.03 | 1.89–4.84 |
Hospital cost >$18,187.88b | 432 (60.3%) | 39 (41.5%) | 0.001 | 2.13 | 1.38–3.30 |
Mortalityb | 21 (2.9%) | 0 (0.0%) | 0.157 | ||
Mortality and vegetative stateb | 23 (3.3%) | 0 (0.0%) | 0.097 | ||
Moderate and worseb | 83 (12.0%) | 4 (4.3%) | 0.032 | 3.01 | 1.07–8.42 |
Boldface indicates statistical significance (p ≤ 0.05).
Unadjusted odds ratio.
n (%).
Median (Interquartile Range).